Effect of Tiltailadi Nasya in comparison with Occlusion Therapy in the management of Anisometropic Amblyopia (Pratham patalgat Timir)

Effect of Tiltailadi Nasya in the comparison with Occlusion Therapy in the management of Anisometropic Amblyopia w.s.r to Pratham patalgat Timir: Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/078893

Enrollment

Registered

2025-01-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H530- Amblyopia ex anopsia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient which shows symptoms of Anisometropic Amblyopia. Patient age group 15-30 yrs. Patient irrespective of sex, educational status, socio economic status, marital status, caste etc

Exclusion criteria

Exclusion criteria: Strabismic Amblyopia. Toxic Amblyopia. Idiopathic Amblyopia. Organic Amblyopia. Any ocular lesion

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Tiltailadi Nasya in comparison with Occlusion therapy in the management of Anisometropic Amblyopia w.s.r to Pratham patalgat TimirTimepoint: At the end of 30days	—

Secondary

Measure	Time frame
To see effect of Tiltailadi Nasya in reduction of dioptric power by using lens.Timepoint: At the end of 30days	—

Countries

India

Contacts

Public ContactDr Kalyani Rajesh Dhawale

Shri Ayurved Mahavidyalaya Nagpur

drgovind2005@gmail.com9860166089

Outcome results